C
46
2
GILD
28
2
PX
15
2
NEE
54
-3
AMZN
59
4
DRI
48
-12
XOM
51
-9
APH
73
2
BLK
49
3
VRSK
40
-2
HAL
50
-4
MTCH
50
2
RRC
76
-2
HCP
78
-2
UHS
62
-2
MLM
76
2
WAT
53
3
SO
59
-3
FOX
33
-6
BEN
52
10
C
46
2
GILD
28
2
PX
15
2
NEE
54
-3
AMZN
59
4
DRI
48
-12
XOM
51
-9
APH
73
2
BLK
49
3
VRSK
40
-2
HAL
50
-4
MTCH
50
2
RRC
76
-2
HCP
78
-2
UHS
62
-2
MLM
76
2
WAT
53
3
SO
59
-3
FOX
33
-6
BEN
52
10
Financhill
Back

MillerKnoll 10K Form

Buy
70

MLKN
MillerKnoll

Last Price:
25.74
Seasonality Move:
7.79%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MLKN News And Ratings

See the #1 stock for the next 7 days that we like better than MLKN

MLKN Financial Statistics

Sales & Book Value

Annual Sales: $4.09B
Cash Flow: $43.9M
Price / Cash Flow: 6.72
Annual Sales: $19.10
Price / Book: 1.33

Profitability

EPS (TTM): 0.96870
Net Income (TTM): $72.3M
Gross Margin: $1.43B
Return on Equity: 4.73%
Return on Assets: 1.71%

MillerKnoll Earnings Forecast

Key MillerKnoll Financial Ratios

  • The Gross Profit Margin over the past 40 years for MLKN is 34.99%.
  • The Selling, General & Administrative Expenses for MLKN have been equal to 27.56% of Gross Profit Margin.
  • The Research & Development expenses have been 2.59% of Revenue.
  • The Interest Expense is 175.77% of Operating Income.
  • The Net Earning history of MLKN is 1.03% of Total Revenues.
  • Per Share Earnings over the last 40 years have been positive in 25 years.

MillerKnoll Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Commercial Services & Supplies
Sector: Industrials
Current Symbol: MLKN
Website: millerknoll.com

Debt

Debt-to-Equity Ratio: 0.96
Current Ratio: 1.59
Quick Ratio: 0.8

Price-to-Earnings

Trailing P/E Ratio: 46.78
Forward P/E Ratio: 11.72

MLKN Technical Analysis vs Fundamental Analysis

Buy
70
MillerKnoll (MLKN) is a Buy

Is MillerKnoll a Buy or a Sell?

  • MillerKnoll stock is rated a Buy
    The current MillerKnoll [MLKN] share price is $25.73. The Score for MLKN is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.